CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $556,135 | -30.1% | 132,413 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $795,802 | -22.4% | 132,413 | -24.8% | 0.00% | -40.0% |
| Q3 2022 | $1,025,000 | -2.6% | 176,198 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $1,052,000 | +27.8% | 176,198 | 0.0% | 0.01% | +66.7% |
| Q1 2022 | $823,000 | +20.1% | 176,198 | -36.2% | 0.00% | +50.0% |
| Q4 2021 | $685,000 | +31.7% | 276,198 | +56.8% | 0.00% | 0.0% |
| Q3 2021 | $520,000 | +173.7% | 176,198 | +131.2% | 0.00% | +100.0% |
| Q2 2021 | $190,000 | -14.4% | 76,198 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $222,000 | -9.4% | 76,198 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $245,000 | +49.4% | 76,198 | -0.0% | 0.00% | 0.0% |
| Q3 2020 | $164,000 | +86.4% | 76,211 | 0.0% | 0.00% | – |
| Q2 2020 | $88,000 | +25.7% | 76,211 | 0.0% | 0.00% | – |
| Q1 2020 | $70,000 | -13.6% | 76,211 | +48.8% | 0.00% | – |
| Q4 2019 | $81,000 | +88.4% | 51,211 | 0.0% | 0.00% | – |
| Q3 2019 | $43,000 | -2.3% | 51,211 | +0.0% | 0.00% | – |
| Q2 2019 | $44,000 | -12.0% | 51,198 | 0.0% | 0.00% | – |
| Q1 2019 | $50,000 | +31.6% | 51,198 | 0.0% | 0.00% | – |
| Q4 2018 | $38,000 | -65.8% | 51,198 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $111,000 | -56.5% | 51,198 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $255,000 | +86.1% | 51,198 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $137,000 | -18.9% | 51,198 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $169,000 | -21.8% | 51,198 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $216,000 | – | 51,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|